The announcement coincides with Gum Disease Awareness Month, which is recognized by official proclamation in all 50 states, multiple territories and several Canadian provinces to promote early detection and treatment. Gum disease – or periodontal disease – affects up to 85% of adults and is the leading cause of tooth loss.
Developed for the treatment of moderate to severe periodontal disease, the minimally invasive LANAP protocol helps save natural teeth by significantly reducing harmful bacteria, preserving healthy tissue and regenerating alveolar bone without cutting and stitches.
The new patent builds on the company’s existing patented procedures for the elimination of disease and regeneration of bone, periodontal ligament and cementum on a previously diseased root surface using the PerioLase MVP-7.
“This further solidifies our position as the leader in dental laser-assisted regeneration technology and innovative procedures such as the LANAP protocol,” said Robert H. Gregg II, DDS, Founder, President and Chairman of the Board at Millennium Dental Technologies. “Combined with our other patents, it protects years of research supporting the LANAP protocol and other proprietary laser procedures only available using our PerioLase MVP-7 dental laser.”
Other unique procedures available only with the PerioLase MVP-7 include the following:
- LAPIP™ protocol to save ailing and failing dental implants,
- BLAST™ protocol to prevent peri-implantitis and enhance implant integration, and
- VAPS™ (Value-Added Procedures), dozens of soft- and hard-tissue laser techniques ranging from the treatment of TMJ, hemangiomas and fibromas to depigmentation, hemostasis and decontamination of tooth extraction sockets.
Every year, Millennium Dental Technologies initiates its annual pledge to provide complimentary LANAP treatment to approximately 100 patients through its collaboration with the Institute for Advanced Laser Dentistry (IALD), a non-profit educational and research organization dedicated to eradicating periodontitis. Since inception, the annual pledge has benefitted more than 1600 patients and represents more than $16 million in free dental treatment.
Headquartered in Cerritos, CA, Millennium Dental Technologies is the developer of the LANAP protocol for the treatment of periodontal disease and the manufacturer of the PerioLase MVP-7 Nd:YAG free-running pulsed laser. By providing a comfortable experience with unique bone-building clinical results, the company’s FDA-cleared LANAP protocol removes the fear of gum disease treatment, offering a more comfortable and less invasive treatment alternative to conventional surgery. The company’s founding clinician, Robert H. Gregg II, DDS, continues to operate the company with the vision: To create better clinical outcomes in periodontal disease patients and to remain true to the guiding principle, “It’s all about the patient.” For more information, visit www.lanap.com.
SOURCE Millennium Dental Technologies, Inc.
